Pfizer Chantix Trials Show More Heart Troubles In Users: FDA
An analysis of clinical trials has shown that users of Pfizer Inc.'s smoking cessation drug Chantix had a higher occurrence of heart attacks, strokes and other cardiovascular adverse events compared to...To view the full article, register now.
Already a subscriber? Click here to view full article